Astrotechs 1st Detect Announces European CE Certification for MMS-1000
November 18, 2014
Austin, Texas -– 1st Detect Corporation, a subsidiary of Astrotech Corporation (Nasdaq:ASTC), announced today that the MMS-1000 mass spectrometer has met the regulatory requirements for CE certification. The CE testing process ensures the safety and performance of the MMS-1000 according to standard testing methodologies published by the European Commission as IEC 61010-1:2010 (3rd Edition) and [...]
Module transforms Raman microscopes into high throughput chemical analyzers
November 18, 2014
HORIBA Scientific, global leader in Raman spectroscopy systems, announces the release of a new MultiWell module for its acclaimed LabSpec 6 Spectroscopy Suite. The module transforms HORIBA’s Raman microscopes into high throughput chemical analyzers, coupling non-destructive, chemically rich analysis, with high sample turn around and fast return on investment. The MultiWell module is an add-on [...]
November 18, 2014
Marcy l’Etoile, France – San Diego, California, United States –– bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina, a world leader in genomics, announced they have signed an exclusive agreement to launch a next-generation sequencing (NGS) epidemiology solution for service labs. The two companies will jointly develop applications for microbiology [...]
November 18, 2014
SOUTH EASTON, Mass. -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced the installation of its first two Barozyme HT-48 high throughput systems for independent evaluation and subsequent potential sale. One system was placed in the laboratory of Dr. Radoslav Goldman of Georgetown University while the other was placed in the laboratory [...]
Genetic Signatures Prepares for IPO: Prospectus now available
November 18, 2014
Sydney, Australia –- Genetic Signatures Ltd has launched its prospectus offering institutional and retail investors the opportunity to invest in the exciting growing global molecular diagnostics market prior to the Company’s listing on the Australian Stock Exchange on 23 December 2014. Molecular diagnostics (MDx) is a modern technique increasingly used by hospitals and pathology labs [...]
luidigm Announces New High Throughput Workflow for Single-Cell mRNA Sequencing
November 18, 2014
WASHINGTON -- Fluidigm Corporation (NASDAQ: FLDM) announced a new workflow that enables high throughput single-cell mRNA sequencing. This workflow, which was presented today at the Society for Neuroscience Conference, outlines significant advances in integrated fluidic circuit (IFC) design and chemistry to massively increase throughput and ease-of-use while simultaneously decreasing the cost of single-cell preparation. A [...]
Organovo Announces Commercial Release of the exVive3D™ Human Liver Tissue
November 18, 2014
SAN DIEGO -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today announced the full commercial release of the exVive3DTM Human Liver Tissue for preclinical drug discovery testing. Initially, clients will be able to access the technology through Organovo's contract research services program. This model [...]
HALMA ANNOUNCES NEW SECTOR VICE PRESIDENTS
November 17, 2014
Following the changes to Halma's Executive Board, including the promotion of four Sector Chief Executives (‘SCE's) to run Halma's primary business sectors, the company today confirms the appointment of three new Sector Vice Presidents (‘SVP's). Tim Prestidge Paul Simmons Todd Burt Tim Prestidge joined Halma in early November 2014 and he will work in the [...]
November 17, 2014
BOTHELL, Wash. -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"), today announced it has launched two new improved packaging options for its BloodStor and CryoStor cryopreservation freeze media [...]
November 17, 2014
SOUTH SAN FRANCISCO, Calif. – Sequenta, Inc., a biotechnology company developing clinical diagnostics based on immune cell receptor genes, today announced that the company has entered into an agreement with Illumina, Inc. (NASDAQ: ILMN). The purpose of the agreement is to commercialize an in vitro diagnostic (IVD) kit that will enable clinical laboratories to utilize [...]

